Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity

Erol M. K. , Coban D. T. , Sari E. , Bilgin A. B. , Dogan B., Ozdemir O., ...More

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, vol.78, no.6, pp.340-343, 2015 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 78 Issue: 6
  • Publication Date: 2015
  • Doi Number: 10.5935/0004-2749.20150090
  • Title of Journal : ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
  • Page Numbers: pp.340-343
  • Keywords: Retinopathy of prematurity, Vascular endothelial growth factor A, Antibodies, monoclonal, Angiogenesis inhibitors, Intravitreal injections, ENDOTHELIAL GROWTH-FACTOR, ZONE-I, THERAPY, INJECTION, LASER, AVASTIN

Abstract

Purpose: To compare the efficacy of intravitreal ranibizumab and bevacizumab treatment for type 1 retinopathy of prematurity (ROP).